Ertugliflozin + Sitagliptin
Composition
This formulation contain combination of Ertugliflozin and Sitagliptin l as active agent
Indications
the treatment of type 2 diabetes mellitus in adults
Side effects
urinary tract infections, upper respiratory tract infections, nasopharyngitis, headache, and hypoglycemia
Precautions
aution is advised in patients with a history of genital mycotic infections or urinary tract infections and pancreatitis
Contraindications
Contraindications include severe renal impairment, end-stage renal disease
Dosage and administration
directed by a healthcare professional
Countries
Available Forms
Tablet
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai